Brimonidine Tartrate/timolol Maleate Ophthalmic Solution
Product Images NDC 69315-330

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate/timolol Maleate Ophthalmic Solution (NDC 69315-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-timolol-10ml-carton (Brimonidine Timolol 10ml Carton)

Brimonidine-timolol-10ml-carton (Brimonidine Timolol 10ml Carton)
This is a product label for a pharmaceutical item, likely an eye drop solution, manufactured by Caplin Steriles Limited in India for Leading Pharma, LLC in the USA. The product contains brimonidine tartrate and timolol, with specific instructions for use including dosage and storage conditions. It also mentions the inclusion of benzalkonium preservative and provides information on the active and inactive ingredients. The label indicates details that will be printed during batch overprinting, including 2D code, lot number, expiration date, etc.*
FDA Label Image

Brimonidine-timolol-10ml-container (Brimonidine Timolol 10ml Container)

Brimonidine-timolol-10ml-container (Brimonidine Timolol 10ml Container)
This is a prescription medication labeled as Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution at strength 0.2%/0.5%. It is indicated for eye use only. Each ml contains brimonidine tartrate 0.2% and timolol 0.5%. The preservative used is benzalkonium chloride (0.005%). The usual dosage is one drop twice daily in the affected eye. It should be stored at 20° - 25°C (68° - 77°F) and protected from light. This medication is manufactured by CapLIn Steriles Limited in India and distributed in the USA by Leading Pharma, LLC.*
FDA Label Image

Brimonidine-timolol-15ml-carton (Brimonidine Timolol 15ml Carton)

Brimonidine-timolol-15ml-carton (Brimonidine Timolol 15ml Carton)
This text describes a pharmaceutical product, specifically a Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution. The solution is intended for eye use only and comes in a 15mL container. The active ingredients are brimonidine tartrate (0.2%) and timolol (0.5%), with a preservative of benzalkonium chloride (0.005%). The usual dosage is one drop twice daily in the affected eye(s), and it should be stored at 20° - 25°C. The solution is sterile and includes other inactive ingredients such as sodium phosphate and hydrochloric acid. The product is manufactured for Leading Pharma LLC in the USA by Caplin Steriles Limited in India. The solution will have batch overprinting with 2D Cod, Sr. No, GTIN, Lot number, and Exp date details during online packing.*
FDA Label Image

Brimonidine-timolol-15ml-container (Brimonidine Timolol 15ml Container)

Brimonidine-timolol-15ml-container (Brimonidine Timolol 15ml Container)
This is a prescription ophthalmic solution containing Brimonidine Tartrate/Timolol Maleate with 0.25% and 0.5% respectively. It is used for the affected eye(s) with a usual dosage of one drop twice daily. This product is preserved with benzalkonium chloride at a concentration of 0.005%. The recommended storage temperature is between 20° - 25°C (68° - 77°F) with protection from light. Manufactured by Caplin Steriles Limited for Leading Pharma, LLC. It is intended for eye use only.*
FDA Label Image

Brimonidine-timolol-5ml-carton (Brimonidine Timolol 5ml Carton)

Brimonidine-timolol-5ml-carton (Brimonidine Timolol 5ml Carton)
This text provides information about a pharmaceutical product for the eyes in a 5mL bottle. The product contains brimonidine tartrate and timolol maleate in a specific concentration and includes instructions for use, storage recommendations, and details about the manufacturer. Additionally, it mentions the inclusion of preservatives and inert ingredients, along with the usual dosage.*
FDA Label Image

Brimonidine-timolol-5ml-container (Brimonidine Timolol 5ml Container)

Brimonidine-timolol-5ml-container (Brimonidine Timolol 5ml Container)
This is a prescription eye solution containing brimonidine tartrate 0.2% and timolol 0.5%, preserved with benzalkonium chloride at 0.005%. It is recommended to use one drop in the affected eye(s) twice daily. The product should be stored between 20°C - 25°C (68°F - 77°F) and protected from light. It is manufactured by Caplin Steriles Limited in India for Leading Pharma, LLC in the USA.*
FDA Label Image

Brimonidine-timolol-brimo-structure (Brimonidine Timolol Brimo Structure)

FDA Label Image

Brimonidine-timolol-timo-structure (Brimonidine Timolol Timo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.